News
PETS
22.07
-0.68%
-0.15
PetMed Express Q3 2023 Earnings Preview
Seeking Alpha · 17h ago
Earnings Preview: PetMed Express
Benzinga · 23h ago
Pets at Home sees FY 2023 underlying pretax profit at upper end of consensus
MarketWatch · 4d ago
PetMed stock dips amid disclosure of deal amount for PetCareRx acquisition
Seeking Alpha · 01/19 17:02
BRIEF-PetMeds To Acquire Petcarerx
Reuters · 01/17 15:23
PetMeds to expand customer, product base with PetCareRx buyout
Seeking Alpha · 01/17 14:44
TDV: The Underlying Index Looks Unattractive
Seeking Alpha · 01/17 12:30
PetMed Express to Acquire PetCareRx, Terms Undisclosed
PetMed Express to Acquire PetCareRx, Terms Undisclosed
MT Newswires · 01/17 09:23
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $18
Benzinga · 11/08/2022 14:21
--Jefferies & Co Adjusts PetMed Express Price Target to $19 From $20, Maintains Hold Rating
--Jefferies & Co Adjusts PetMed Express Price Target to $19 From $20, Maintains Hold Rating
MT Newswires · 11/08/2022 13:05
--Morgan Stanley Adjusts Price Target on PetMed Express to $18 From $19, Maintains Underweight Rating
--Morgan Stanley Adjusts Price Target on PetMed Express to $18 From $19, Maintains Underweight Rating
MT Newswires · 11/08/2022 11:43
Here's What's Concerning About PetMed Express' (NASDAQ:PETS) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Simply Wall St. · 11/08/2022 11:30
BRIEF-PetMeds Announces Its Second Quarter Financial Results, Declares A Quarterly Dividend Of $0.30 Per Share
Reuters · 11/07/2022 22:48
PetMed Express declares $0.30 dividend
Seekingalpha · 11/07/2022 21:12
PetMed Express Q2 EPS $0.13 Misses $0.25 Estimate, Sales $65.39M Miss $65.55M Estimate
Benzinga · 11/07/2022 21:02
PetMed Express GAAP EPS of $0.13, revenue of $65.4M
Seekingalpha · 11/07/2022 21:02
PetMed Express Q2 EPS, Sales Decline
PetMed Express Q2 EPS, Sales Decline
MT Newswires · 11/07/2022 16:45
-- Earnings Flash (PETS) PETMED EXPRESS Posts Q2 Revenue $65.4M, vs. Street Est of $65.4M
-- Earnings Flash (PETS) PETMED EXPRESS Posts Q2 Revenue $65.4M, vs. Street Est of $65.4M
MT Newswires · 11/07/2022 16:23
More
Webull provides a variety of real-time PETS stock news. You can receive the latest news about Petmed Express Inc through multiple platforms. This information may help you make smarter investment decisions.
About PETS
PetMed Express, Inc. is a pet pharmacy, which is engaged in delivering prescription and non-prescription pet medications and other health products for dogs, cats and horses through its website at petmeds.com, as well as through its toll-free number. The Company's product line contains approximately 3,000 SKUs of pet medications, health products, and supplies. It offers various pet supplies, including food, beds, crates, stairs and other pet supplies. The Company's products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.